MOLECULAR TARGETING TECHNOLOGIES, INC.
mtarget.com
WEST CHESTER, United States · Founded 2015 · $139.0M raised
- Headquarters
- WEST CHESTER, Pennsylvania
- Employees
- 1–10
- Founded
- 2015
- Business Model
- B2B
- Website
- mtarget.com
- Total Funding
- $139.0M
- Last Round
- $109.0M Venture RoundJun 2024
- Rounds
- 2
About
MTTI is a clinical-stage biotechnology company focused on diagnostic and therapeutic molecules for unmet medical needs in cancer and infection. Centocor spinoff. PSVue, CellVue, NeuroVue. Multiple SBIR/STTR awards.
Summary
MOLECULAR TARGETING TECHNOLOGIES, INC. is a Biotech company based in WEST CHESTER, United States, founded in 2015. It has raised $139.0M in total across 2 rounds, most recently a $109.0M Venture Round round in Jun 2024. Investors include Multiple investors.
Tech & App Stack
1 technologies & apps tracked
Create a free account — 25 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 25 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Jun 2024
Sign up to see all 2 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biopharmaceutical services company
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Global oncology biopharmaceutical company developing and commercializing cancer treatments, now r...